Palbociclib + rapamycin

Palbociclib + rapamycin has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Feb 16, 2026: “Palbociclib and Rapamycin pretreatment boosted the persistence and functionality of CAR-T cells in solid tumors through metabolic reprogramming”.

See all 1 papers on palbociclib + rapamycin